The first mRNA COVID-19 vaccine of India gets approval for further clinical trials

- Advertisement - (adsbygoogle = window.adsbygoogle || []).push({});

Mumbai, India (CU)_ The Indian drug regulator, the Drugs Controller General of India (DCGI),  has approved phase II and III clinical trials of HGCO19, which is the first mRNA COVID-19 vaccine candidate in the nation. Under the COVID-19 suraksha mission, Gennova Biopharmaceuticals is developing the vaccine in collaboration with the Department of Biotechnology and the Biotechnology Industry Research Assistance Council (BIRAC).

According to the the statement from the federal ministry of science and technology…

A Personal Note from the Publisher" Small photo of you, with your signature beneath

A Personal Note from the Publisher

My dear friend, thank you for your time with us today. This site was built for you, the members of the Commonwealth Family, and nothing matters more to me than hearing your voice and feedback.

What did you make of this article? Did it inform you, challenge you, or leave you wanting more?

Please tell me. I read your replies personally and they help shape everything we publish.

With warmest wishes,
Hon. Nirj Deva
Founder and Publisher.

Free, always. We'll never sell your details.

Hot this week

Test post title

Test post content

Test post title

Test post content

Canada Pledges C$110 Million to Strengthen Caribbean Fight Against Transnational Crime

Canada is committing C$110 million to help Caribbean countries...

South Africa’s ANC Suffers Major Electoral Setback as Coalition Politics Gain Momentum

Recent local elections in South Africa have delivered a...
- Advertisement - (adsbygoogle = window.adsbygoogle || []).push({});

Related Articles

- Advertisement -sitaramatravels.comsitaramatravels.com

Popular Categories